Ocumension Therapeutics (1477.HK)
HKD 4.56
(-1.72%)
HKD 4.56
(-1.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -177.92 Million | -200.65 Million | -196.84 Million | -212.57 Million | -108.08 Million | -43.35 Million |
| Net Income | -379.48 Million | -402.22 Million | -259.99 Million | -2.26 Billion | -1.32 Billion | -209.4 Million |
| Depreciation & Amortization | 57.53 Million | 40.45 Million | 13.89 Million | 4.65 Million | 1.2 Million | 64 Thousand |
| Deferred income taxes | - | - | 23.56 Million | 1.79 Billion | 1.17 Billion | 159.97 Million |
| Stock-based compensation | 139.72 Million | 218.79 Million | 188.11 Million | 293.58 Million | 46.8 Million | 3.68 Million |
| Change in working capital | 33.15 Million | -12.87 Million | -35.49 Million | -22.31 Million | 860 Thousand | 2.35 Million |
| Other non-cash items | -20.74 Million | -44.8 Million | -126.93 Million | -14.19 Million | -3.81 Million | -20 Thousand |
| Investing Cash Flow | -259.78 Million | 229.14 Million | -1.34 Billion | 629.69 Million | -979.91 Million | -66.66 Million |
| Investments in PPE | -361.86 Million | -310 Million | -664.8 Million | -304.6 Million | -766 Thousand | -278 Thousand |
| Acquisitions | - | - | -848 Thousand | -119.37 Million | - | 25 Thousand |
| Investment purchases | -771.13 Million | -2.03 Billion | -3.14 Billion | -1.32 Billion | -2.04 Billion | -102.87 Million |
| Sales/Maturities of investments | 824.36 Million | 2.55 Billion | 2.44 Billion | 2.39 Billion | 1.06 Billion | 36.7 Million |
| Other Investing Activities | 21.44 Million | 16.29 Million | 17.3 Million | -16.27 Million | -449 Thousand | -240 Thousand |
| Financing Cash Flow | 108.66 Million | -9.22 Million | 668.85 Million | 1.52 Billion | 1.24 Billion | 136.98 Million |
| Debt repayment | -118.19 Million | -9.14 Million | -3.81 Million | -1.38 Million | -939 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.46 Million | -11 Million | -1.38 Million | - | - | - |
| Common Stock Issuance | 5.59 Million | 12.72 Million | 684.73 Million | 1.61 Billion | 21 Thousand | 68.3 Million |
| Other Financing Activities | 122.56 Million | 7.35 Million | -6.86 Million | -82.39 Million | 1.24 Billion | 68.67 Million |
| Accounts receivables | -7.65 Million | -33.27 Million | -31.14 Million | -28.13 Million | -8.6 Million | -1.31 Million |
| Accounts payables | - | 33.27 Million | 31.14 Million | 28.13 Million | 8.6 Million | - |
| Inventory | -13 Million | -19.11 Million | -1.96 Million | -2.76 Million | -259 Thousand | - |
| Other working capital | 4.24 Million | 6.23 Million | -33.53 Million | -19.54 Million | 1.11 Million | - |
| Cash at beginning of period | 1.17 Billion | 1.12 Billion | 2.03 Billion | 192.4 Million | 25.62 Million | - |
| Cash at end of period | 842.83 Million | 1.17 Billion | 1.12 Billion | 2.03 Billion | 192.4 Million | 25.62 Million |
| Capital Expenditure | -361.86 Million | -310 Million | -664.8 Million | -304.6 Million | -766 Thousand | -278 Thousand |
| Effect of forex changes on cash | 1.84 Million | 25.56 Million | -35.81 Million | -102.56 Million | 13.15 Million | -1.34 Million |
| Net cash flow / Change in cash | -327.21 Million | 44.82 Million | -909.09 Million | 1.84 Billion | 166.77 Million | 25.62 Million |
| Free Cash Flow | -539.79 Million | -510.66 Million | -861.65 Million | -517.18 Million | -108.85 Million | -43.62 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -379.48 Million | -85.69 Million | -85.69 Million | -104.2 Million | -104.2 Million | -402.22 Million |
| Depreciation & Amortization | 57.53 Million | 14.3 Million | 14.3 Million | 14.46 Million | 14.46 Million | 40.45 Million |
| Deferred income taxes | - | - | - | -109.66 Million | -45.94 Million | - |
| Stock-based compensation | 139.72 Million | 28.61 Million | 28.61 Million | 41.25 Million | 41.25 Million | 218.79 Million |
| Change in working capital | 33.15 Million | -14.14 Million | -14.14 Million | 5.93 Million | 5.93 Million | -12.87 Million |
| Other non-cash items | -20.74 Million | 26.76 Million | 26.76 Million | -16.26 Million | -16.26 Million | -44.8 Million |
| Investing Cash Flow | -259.78 Million | 129.66 Million | 129.66 Million | -259.55 Million | -259.55 Million | 229.14 Million |
| Investments in PPE | -361.86 Million | -27.98 Million | -27.98 Million | -12.47 Million | -12.47 Million | -310 Million |
| Acquisitions | - | - | - | 406.4 Million | - | - |
| Investment purchases | -771.13 Million | - | - | -711.25 Million | - | -2.03 Billion |
| Sales/Maturities of investments | 824.36 Million | - | - | 304.85 Million | - | 2.55 Billion |
| Other Investing Activities | 21.44 Million | 157.65 Million | 157.65 Million | -247.08 Million | -247.08 Million | 16.29 Million |
| Financing Cash Flow | 108.66 Million | 56.28 Million | 56.28 Million | -1.95 Million | -1.95 Million | -9.22 Million |
| Debt repayment | -118.19 Million | - | - | -2.04 Million | - | -9.14 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.46 Million | -731 Thousand | -731 Thousand | - | - | -11 Million |
| Common Stock Issuance | 5.59 Million | - | - | 5.19 Million | - | 12.72 Million |
| Other Financing Activities | 122.56 Million | 57.01 Million | 57.01 Million | -1.95 Million | -1.95 Million | 7.35 Million |
| Accounts receivables | -7.65 Million | -13.36 Million | -13.36 Million | 9.54 Million | 9.54 Million | -33.27 Million |
| Accounts payables | - | - | - | -13.59 Million | - | 33.27 Million |
| Inventory | -13 Million | -1.65 Million | -1.65 Million | -4.85 Million | -4.85 Million | -19.11 Million |
| Other working capital | 4.24 Million | 877.5 Thousand | 877.5 Thousand | 1.24 Million | 1.24 Million | 6.23 Million |
| Cash at beginning of period | 1.17 Billion | - | - | 1.34 Billion | - | 1.12 Billion |
| Cash at end of period | 842.83 Million | 152.89 Million | 152.89 Million | 605.15 Million | -316.5 Million | 1.17 Billion |
| Capital Expenditure | -361.86 Million | -27.98 Million | -27.98 Million | -12.47 Million | -12.47 Million | -310 Million |
| Effect of forex changes on cash | 1.84 Million | -2.9 Million | -2.9 Million | 3.82 Million | 3.82 Million | 25.56 Million |
| Net cash flow / Change in cash | -327.21 Million | 152.89 Million | 152.89 Million | -737.69 Million | -316.5 Million | 44.82 Million |
| Free Cash Flow | -539.79 Million | -58.13 Million | -58.13 Million | -71.28 Million | -71.28 Million | -510.66 Million |
BSDGY
CFEB
ALINV
IEP
BHP
031330